Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GOLGA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHCHD5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPS21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBGCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLR2J4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KCNC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC85B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BID - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF732 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGBL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DNAJC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATC1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA68 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on